Unichem gets USFDA nod for Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg

Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure

Unichem Laboratories is pleased to announce that it has received ANDA approval for its Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Cardura (Doxazosin) Tablets, 1 mg, 2 mg, 4 mg and 8 mg, of Viatris Specialty, LLC.

Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure. The product will be commercialised from Unichem’s Goa Plant.

ANDA approvalDoxazosin TabletsUnichem LaboratoriesUSFDA
Comments (0)
Add Comment